Brainstorm Cell Therapeutics Stock Investor Sentiment

BCLI Stock  USD 1.89  0.10  5.03%   
Under 61% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
few days ago at investing.com         
Brainstorm Cell Therapeutics faces Nasdaq delisting
Investing News at Macroaxis
over a week ago at news.google.com         
BrainStorm Cell Therapeutics announces pricing of 4M registered direct offering - MSN
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Brainstorm Cell Therapeutics Cut to Sell at StockNews.com
news
over two weeks ago at finance.yahoo.com         
BCLI Plans Coming Together for Phase 3b Trial of NurOwn in ALS
Yahoo News
over two weeks ago at www.macroaxis.com         
Acquisition by Arbel Irit of 30666 shares of Brainstorm Cell subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
BrainStorm Issues 2024 Letter to Shareholders
Yahoo News
over a month ago at finance.yahoo.com         
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
Yahoo News
over a month ago at finance.yahoo.com         
BrainStorm Strengthens Exosome Patent Portfolio Receives Notice of Allowance for U.S. Patent Coverin...
Yahoo News
over a month ago at finance.yahoo.com         
BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotro...
Yahoo News
over two months ago at thelincolnianonline.com         
Brainstorm Cell Therapeutics Inc. Short Interest Update
news
over two months ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Expands Stake in Brainstorm Cell Therapeutics Inc
Gurufocus Stories at Macroaxis
over two months ago at news.google.com         
BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate U...
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn Phase 3b Trial Manufacturing - Yaho...
Google News at Macroaxis
over two months ago at seekingalpha.com         
BrainStorm Cell Therapeutics regains compliance with Nasdaq
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Brainstorm Cell that are available to investors today. That information is available publicly through Brainstorm media outlets and privately through word of mouth or via Brainstorm internal channels. However, regardless of the origin, that massive amount of Brainstorm data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Brainstorm Cell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Brainstorm Cell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Brainstorm Cell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Brainstorm Cell alpha.

Brainstorm Cell Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device